Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.32
0.000.00%
Pre-Market: 5:59 AM EDT
Comments
Loading...
Agilon Health Analyst Ratings and Price Targets | NYSE:AGL | Benzinga
Agilon Health Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Agilon Health Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
Stifel
Bernstein
Citigroup
Macquarie
1calculated from analyst ratings
Analyst Ratings for Agilon Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/26/2025 | Buy Now | — | RBC Capital | Sean Dodge49% | $3 → $3.5 | Maintains | Outperform | Get Alert |
| 02/26/2025 | Buy Now | — | Citizens Capital Markets | Constantine Davides37% | — | Reiterates | Market Perform → Market Perform | Get Alert |
| 02/26/2025 | Buy Now | — | Stifel | Craig Jones57% | $2 → $3 | Maintains | Hold | Get Alert |
| 02/26/2025 | Buy Now | — | Needham | Ryan MacDonald57% | — | Reiterates | Hold → Hold | Get Alert |
| 01/15/2025 | Buy Now | — | Bernstein | Amir Farahan 1% | $2.5 → $3.15 | Maintains | Market Perform | Get Alert |
| 01/10/2025 | Buy Now | — | Citigroup | Daniel Grosslight42% | $1.75 → $2.25 | Upgrade | Sell → Neutral | Get Alert |
| 01/10/2025 | Buy Now | — | Needham | Matthew Sheerin69% | — | Reiterates | Hold → Hold | Get Alert |
| 12/16/2024 | Buy Now | — | Macquarie | Tao Qiu45% | → $3 | Initiates | → Neutral | Get Alert |
| 12/11/2024 | Buy Now | — | Bernstein | Lance Wilkes61% | → $2.5 | Initiates | → Market Perform | Get Alert |
| 11/19/2024 | Buy Now | — | RBC Capital | Sean Dodge49% | $3 → $3 | Reiterates | Outperform → Outperform | Get Alert |
| 11/13/2024 | Buy Now | — | Citigroup | Daniel Grosslight42% | $2.5 → $1.75 | Maintains | Sell | Get Alert |
| 11/12/2024 | Buy Now | — | Stifel | Craig Jones57% | $7 → $2 | Maintains | Hold | Get Alert |
| 11/11/2024 | Buy Now | — | TD Cowen | Gary Taylor59% | $6 → $2 | Maintains | Hold | Get Alert |
| 11/11/2024 | Buy Now | — | Barclays | Andrew Mok52% | $5 → $2 | Maintains | Underweight | Get Alert |
| 11/11/2024 | Buy Now | — | JMP Securities | Constantine Davides37% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 11/08/2024 | Buy Now | — | William Blair | Ryan Daniels20% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/29/2024 | Buy Now | — | Citigroup | Daniel Grosslight42% | $7 → $2.5 | Downgrade | Neutral → Sell | Get Alert |
| 10/08/2024 | Buy Now | — | Evercore ISI Group | Elizabeth Anderson46% | $7 → $4 | Maintains | In-Line | Get Alert |
| 10/02/2024 | Buy Now | — | B of A Securities | Kevin Fischbeck67% | → $3 | Downgrade | Buy → Underperform | Get Alert |
| 08/09/2024 | Buy Now | — | Deutsche Bank | George Hill61% | $5 → $4 | Maintains | Hold | Get Alert |
| 08/08/2024 | Buy Now | — | Benchmark | Bill Sutherland62% | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 08/07/2024 | Buy Now | — | RBC Capital | Sean Dodge49% | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 07/09/2024 | Buy Now | — | Evercore ISI Group | Elizabeth Anderson46% | $5.5 → $7 | Maintains | In-Line | Get Alert |
| 05/30/2024 | Buy Now | — | Baird | Michael Halloran67% | → $6 | Initiates | → Neutral | Get Alert |
| 05/24/2024 | Buy Now | — | Truist Securities | Jailendra Singh37% | $6.4 → $6.5 | Maintains | Hold | Get Alert |
| 05/01/2024 | Buy Now | — | Stifel | Craig Jones57% | $8 → $7 | Maintains | Hold | Get Alert |
| 04/22/2024 | Buy Now | — | Citigroup | Daniel Grosslight42% | → $6 | Initiates | → Neutral | Get Alert |
| 04/15/2024 | Buy Now | — | Truist Securities | Jailendra Singh37% | $7.5 → $6.4 | Maintains | Hold | Get Alert |
| 03/06/2024 | Buy Now | — | Barclays | Andrew Mok52% | → $5 | Initiates | → Underweight | Get Alert |
| 02/29/2024 | Buy Now | — | Truist Securities | Jailendra Singh37% | $10 → $7.5 | Maintains | Hold | Get Alert |
| 02/29/2024 | Buy Now | — | Benchmark | Bill Sutherland62% | $13 → $9 | Maintains | Buy | Get Alert |
| 02/28/2024 | Buy Now | — | Evercore ISI Group | Elizabeth Anderson46% | $7 → $6 | Maintains | In-Line | Get Alert |
| 02/28/2024 | Buy Now | — | RBC Capital | Sean Dodge49% | $11 → $8 | Maintains | Outperform | Get Alert |
| 02/26/2024 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $16 → $8 | Maintains | Overweight | Get Alert |
| 02/26/2024 | Buy Now | — | TD Cowen | Gary Taylor59% | $12 → $6.5 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/22/2024 | Buy Now | — | Stifel | Craig Jones57% | $10 → $9 | Maintains | Hold | Get Alert |
| 01/08/2024 | Buy Now | — | Wolfe Research | Justin Lake32% | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 01/05/2024 | Buy Now | — | Truist Securities | Jailendra Singh37% | $23 → $10 | Downgrade | Buy → Hold | Get Alert |
| 01/05/2024 | Buy Now | — | JP Morgan | Lisa Gill58% | $17 → $9 | Downgrade | Overweight → Neutral | Get Alert |
| 12/13/2023 | Buy Now | — | JP Morgan | Lisa Gill58% | $36 → $17 | Maintains | Overweight | Get Alert |
| 12/11/2023 | Buy Now | — | Goldman Sachs | Jamie Perse60% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/06/2023 | Buy Now | — | JMP Securities | Constantine Davides37% | → $18 | Initiates | → Market Outperform | Get Alert |
| 11/21/2023 | Buy Now | — | Deutsche Bank | George Hill61% | $27 → $12 | Downgrade | Buy → Hold | Get Alert |
| 11/15/2023 | Buy Now | — | Benchmark | Bill Sutherland62% | $28 → $22 | Maintains | Buy | Get Alert |
| 11/13/2023 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $23 → $16 | Maintains | Overweight | Get Alert |
| 11/09/2023 | Buy Now | — | Truist Securities | Jailendra Singh37% | $27 → $23 | Maintains | Buy | Get Alert |
| 11/09/2023 | Buy Now | — | Goldman Sachs | Jamie Perse60% | $25 → $22 | Maintains | Buy | Get Alert |
| 11/03/2023 | Buy Now | — | RBC Capital | Sean Dodge49% | $28 → $23 | Maintains | Outperform | Get Alert |
| 10/20/2023 | Buy Now | — | Benchmark | Bill Sutherland62% | → $28 | Initiates | → Buy | Get Alert |
| 08/15/2023 | Buy Now | — | Goldman Sachs | Jamie Perse60% | $29 → $25 | Maintains | Buy | Get Alert |
| 08/15/2023 | Buy Now | — | TD Cowen | Gary Taylor59% | $29 → $25 | Maintains | Outperform | Get Alert |
| 06/20/2023 | Buy Now | — | Truist Securities | Jailendra Singh37% | $35 → $27 | Maintains | Buy | Get Alert |
| 06/13/2023 | Buy Now | — | Evercore ISI Group | Elizabeth Anderson46% | → $22.5 | Initiates | → In-Line | Get Alert |
| 05/31/2023 | Buy Now | — | Goldman Sachs | Jamie Perse60% | $32 → $29 | Maintains | Buy | Get Alert |
| 05/15/2023 | Buy Now | — | Deutsche Bank | George Hill61% | $28 → $27 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | — | RBC Capital | Sean Dodge49% | → $33 | Reiterates | → Outperform | Get Alert |
| 05/10/2023 | Buy Now | — | Stifel | Craig Jones57% | $29 → $20 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | — | Truist Securities | Jailendra Singh37% | $29 → $35 | Maintains | Buy | Get Alert |
| 03/06/2023 | Buy Now | — | Guggenheim | Sandy Draper72% | $21 → $30 | Maintains | Buy | Get Alert |
| 03/03/2023 | Buy Now | — | Deutsche Bank | George Hill61% | $26 → $28 | Maintains | Buy | Get Alert |
| 12/09/2022 | Buy Now | — | Stifel | Craig Jones57% | → $23 | Initiates | → Buy | Get Alert |
| 11/15/2022 | Buy Now | — | Goldman Sachs | Jamie Perse60% | $38 → $34 | Maintains | Buy | Get Alert |
| 11/15/2022 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $28 → $22 | Maintains | Overweight | Get Alert |
| 11/04/2022 | Buy Now | — | SVB Leerink | Whit Mayo68% | $33 → $30 | Maintains | Outperform | Get Alert |
| 09/14/2022 | Buy Now | — | RBC Capital | Sean Dodge49% | → $33 | Initiates | → Outperform | Get Alert |
| 09/12/2022 | Buy Now | — | Goldman Sachs | Jamie Perse60% | → $38 | Initiates | → Buy | Get Alert |
| 09/07/2022 | Buy Now | — | Truist Securities | Jailendra Singh37% | $33 → $29 | Assumes | → Buy | Get Alert |
| 08/08/2022 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $23 → $28 | Maintains | Overweight | Get Alert |
| 08/03/2022 | Buy Now | — | Deutsche Bank | George Hill61% | $29 → $30 | Maintains | Buy | Get Alert |
| 07/14/2022 | Buy Now | — | Truist Securities | David Macdonald64% | $30 → $33 | Maintains | Buy | Get Alert |
| 06/24/2022 | Buy Now | — | BTIG | David Larsen45% | — | Initiates | → Neutral | Get Alert |
| 06/08/2022 | Buy Now | — | Deutsche Bank | George Hill61% | $26 → $26 | Maintains | Buy | Get Alert |
| 05/10/2022 | Buy Now | — | Deutsche Bank | George Hill61% | → $26 | Maintains | Buy | Get Alert |
| 03/31/2022 | Buy Now | — | SVB Leerink | Whit Mayo68% | $25 → $33 | Maintains | Outperform | Get Alert |
| 03/30/2022 | Buy Now | — | Guggenheim | Sandy Draper72% | → $32 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Agilon Health (AGL) stock?
The latest price target for Agilon Health (NYSE:AGL) was reported by RBC Capital on February 26, 2025. The analyst firm set a price target for $3.50 expecting AGL to fall to within 12 months (a possible -18.98% downside). 28 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Agilon Health (AGL)?
The latest analyst rating for Agilon Health (NYSE:AGL) was provided by RBC Capital, and Agilon Health maintained their outperform rating.
When was the last upgrade for Agilon Health (AGL)?
The last upgrade for Agilon Health Inc happened on January 10, 2025 when Citigroup raised their price target to $2.25. Citigroup previously had a sell for Agilon Health Inc.
When was the last downgrade for Agilon Health (AGL)?
The last downgrade for Agilon Health Inc happened on November 11, 2024 when JMP Securities changed their price target from N/A to N/A for Agilon Health Inc.
When is the next analyst rating going to be posted or updated for Agilon Health (AGL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on February 26, 2025 so you should expect the next rating to be made available sometime around February 26, 2026.
Is the Analyst Rating Agilon Health (AGL) correct?
While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $3.00 to $3.50. The current price Agilon Health (AGL) is trading at is $4.32, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.